Quidel Corporation (QDEL) - Product Pipeline Analysis, 2015 Update - New Market Study Published

Quidel Corporation (Quidel) develops, manufactures and markets rapid diagnostic testing solutions that find applications in infectious diseases, gastrointestinal diseases and women’s health. The company offers cell line productsdiagnostic immunoassays including visually read rapid lateral flow tests, ELISAs and fluorescent immunoassaysand others. It offers diagnostic and research assays and reagents in oncology, bone health and inflammatory diseases. Quidel has its manufacturing and research and development facilities in California and others. The company serves physicians, hospitals, clinical laboratories, retail clinics and wellness screening centers. Quidel distributes its products through its direct sales force and also through a network of national and regional distributors. The company has a presence in the US and Germany. Quidel is headquartered in San Diego, California, the US.
The company aims to grow by building a broad product portfolio. In line with its strategy the company managed to receive regulatory approvals for several products such as AmpliVue Trichomonas Assay, Sofia Strep A+ Fluorescent Immunoassay, AmpliVue Bordetella Assay, Lyra Parainfluenza Assay and others.

Full Report Details at
- http://www.fastmr.com/prod/1002549_quidel_corporation_qdel.aspx?afid=301

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

* The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
* The report analyzes all pipeline products in development for the company Quidel Corporation
* The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
* The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
* The report provides detailed description of products in development, technical specification and functions
* The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

* Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
* Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
* To formulate effective Research & Development strategies

About Fast Market Research

Fast Market Research is a leading distributor of market research and business information. Representing the world's top research publishers and analysts, we provide quick and easy access to the best competitive intelligence available. Our unbiased, expert staff is always available to help you find the right research to fit your requirements and your budget.

For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156 (1.413.485.7001 Int'l)

You may also be interested in these related reports:

- Quidel Corporation (QDEL) - Financial and Strategic SWOT Analysis Review
- Integra LifeSciences Holdings Corporation (IART) - Product Pipeline Analysis, 2015 Update
- Luminex Corporation (LMNX) - Product Pipeline Analysis, 2015 Update
- Thoratec Corporation (THOR) - Product Pipeline Analysis, 2015 Update
- Masimo Corporation (MASI) - Product Pipeline Analysis, 2015 Update